Sign up Australia
Proactive Investors - Run By Investors For Investors

Cosmos Holdings transfers its interest in Marathon Global to a cannabis investment firm

As part of the deal, Cosmos will still distribute Marathon Global's line of medical cannabis products
a vial of medical marijuana
Cosmos has a trans-European network of more than 160 clients and vendors

Pharmaceutical wholesaler Cosmos Holdings Inc (OTCQB:COSM) announced Tuesday that it has transferred its interest in the medical cannabis group Marathon Global to the investment firm Kaneh Bosm BioTechnology Inc (CSE:KBB).

Under the terms of the share exchange agreement, Cosmos has swapped its undisclosed stake in Marathon Global for 10 million shares of Kaneh Bosm, a Canadian-listed investment firm that specializes in the acquisition of marijuana projects and cannabis-related companies.

Cosmos will control about 7% of the 141,219,108 shares of stock that Kaneh Bosm issued.

As part of the deal, Cosmos will still distribute Marathon Global’s line of medical cannabis products as well as its cannabis derivatives to its clients in countries where medical cannabis is approved for sale.

BIG PICTURE: Cosmos Holdings focuses on Europe as it expands its global wholesale pharmaceutical business

“I am pleased to announce this agreement will provide Cosmos with additional product lines, all of which we anticipate will increase revenues and profitability on a global scale,” said Cosmos CEO Gregory Siokas in a statement.

Based in Chicago, Cosmos Holdings is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki, Greece and Harlow, UK. The company has a trans-European network of over 160 clients and vendors and conducts business in Germany, the United Kingdom, Ireland, the United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Skopje, Jordan, Sweden, Poland, Netherlands, and Greece.

Kaneh Bosm specializes in the acquisition of marijuana projects and cannabis-related companies while Marathon Global is a private Canadian company specializing in the supply of cannabis.

The use of cannabis for medical purposes is slowly being accepted by governments, with countries such as the Netherlands, Italy and Germany taking the lead with early adoption of regulations. Canada recently legalized the recreational use of marijuana.

Cosmos Holdings shares held steady at US$6.70 in morning trade.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full COSM profile View Profile

Cosmos Holdings Inc Timeline

July 03 2018

Related Articles

scientist in lab
August 31 2018
While the data bodes well for MTD201, Midatech is most excited by the validation of its Q-Sphera sustained release technology, which it is using in some of its other compounds
Vial of pills
June 25 2018
Cosmos is a modern company, but the trade routes it relies on are ancient
picture of cannabis plants
March 24 2018
Control of the supply chain offers operational advantages and financial benefits.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use